Effect of subchronic antidepressant treatments on behavioral, neurochemical, and endocrine changes in the forced-swim test

Pharmacology Biochemistry and Behavior

Volumn 65, Issue 4, 2000, Pages 591-597

  Connor, Thomas J ^a   Kelliher, Padraig ^a   Shen, Yan ^a   Harkin, Andrew ^a   Kelly, John P ^a   Leonard, Brian E ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Amygdala; Antidepressant; Depression; Forced swim test; HPA axis; Noradrenaline; Serotonin; Stress

Indexed keywords

CORTICOSTERONE; DESIPRAMINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; VENLAFAXINE;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DEPRESSION; ENDOCRINE SYSTEM; FORCED SWIMMING TEST; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MALE; NEUROCHEMISTRY; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE; STRESS;

AMYGDALA; ANIMALS; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BEHAVIOR, ANIMAL; BIOGENIC AMINES; BRAIN CHEMISTRY; CEREBRAL CORTEX; CORTICOSTERONE; CYCLOHEXANOLS; DEPRESSIVE DISORDER; DESIPRAMINE; HORMONES; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MOTOR ACTIVITY; PAROXETINE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SWIMMING;

EID: 0034124390     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(99)00192-6     Document Type: Article

References (56)

1. Andrews J.M., Ninan P.T., Nemeroff C.B. Venlafaxine. A novel antidepressant that has a dual mechanism of action Depression. 4:1996;48-56.
2. Araki H., Kawashima K., Uchiyama Y., Aihara H. Involvement of amygdaloid catecholaminergic mechanism in suppressive effects of desipramine and imipramine on duration of immobility in rats forced to swim. Eur. J. Pharmacol. 113:1985;313-318.
3. Beique J.C., DeMontigny C., Blier P., Debonnel G. Blockade of 5-HT and NE reuptake by venlafaxine. In vivo electrophysiological studies in the rat Soc. Neurosci. Abstr. 22:1996;180.
4. Blier P., De Montigny C. Current advances and trends in the treatment of depression. Trends Pharmacol. Sci. 15:1994;220-226.
5. Bolden-Watson C., Richelson E. Blockade by newly developed antidepressants of biogenic amine uptake into rat brain synaptosomes. Life Sci. 52:1993;1023-1029.
6. Borsini F. Role of the serotonergic system in the forced swimming test. Neurosci. Biobehav. Rev. 19:1995;377-395.
7. Borsini F., Meli A. Is the forced swimming test a suitable model for revealing antidepressant activity. Psychopharmacology (Berlin). 94:1988;147-160.
8. Brady L.S., Whitfield H.J., Fox R., Gold P.W., Herkenham M. Long term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase and mineralocorticoid receptor gene expression in the rat. J. Clin. Invest. 87:1991;831-837.
9. Briley M., Moret C. Effect of milnacipran on the serotonin and noradrenaline reuptake processes. Fundamental and clinical implications Intern. J. Neuropsychopharmacol. 1(Suppl. 1):1998;A16.
10. Budziszewska B., Siwanowicz J., Przegalinski E. The effect of chronic treatment with antidepressant drugs on corticosteroid receptor levels in the rat hippocampus. Pol. J. Pharmacol. 46:1994;147-152.
11. Caccia S., Francasso C., Garattini S., Sarati S. Effects of short and long term administration of fluoxetine on the monoamine content of rat brain. Neuropharmacology. 31:1992;343-347.
12. Cannizzaro C., Cannizzaro E., Gagliano M., Mineo A., Sabatino M., Cannizzaro G. Effects of desipramine and alprazolam on forced swimming behaviour of adult rats exposed to prenatal diazepam. Eur. J. Pharmacol. 273:1994;239-245.
13. Centeno V.A., Volosin M. Chronic treatment with desipramine. Effect on endocrine and behavioural responses induced by inescapable stress Pharmacol. Biochem. Behav. 62:1997;939-944.
14. Connor T.J., Kelly J.P., Leonard B.E. Forced swim test-induced neurochemical, endocrine and immune changes in the rat. Pharmacol. Biochem. Behav. 58:1997;961-968.
15. Connor T.J., Kelly J.P., Leonard B.E. Forced swim test-induced endocrine and immune changes in the rat. Effect of subacute desipramine treatment Pharmacol. Biochem. Behav. 59:1998;171-178.
16. Cryan J.F., McGrath C., Leonard B.E., Norman T.R. Combining pindolol and paroxetine in an animal model of chronic antidepressant action - Can early onset of action be detected? Eur. J. Pharmacol. 352:1998;23-28.
17. Detke M.J., Rickels M., Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berlin). 121:1995;66-72.
18. Detke M.J., Johnson J., Lucki I. Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression. Exp. Clin. Psychopharmacol. 5:1997;107-112.
19. Duncan G.E., Knapp D.J., Carson S.W., Breese G.R. Differential effects of chronic antidepressant treatment on swim stress and fluoxetine-induced secretion of corticosterone and progesterone. J. Pharmacol. Exp. Ther. 295:1998;579-587.
20. Duncan G.E., Knapp D.J., Johnson K.B., Breese G.R. Functional classification of antidepressants based on antagonism of swim stress-induced Fos-like immunoreactivity. J. Pharmacol. Exp. Ther. 277:1996;1076-1089.
21. Duncan G.E., Breese G.R., Criswell H., Stumpf W.E., Mueller R.A., Covey J.B. Effects of antidepressant drugs injected into the amygdala on behavioral responses of rats in the forced swim test. J. Pharmacol. Exp. Ther. 238:1986;758-762.
22. Dunn A.J. Stress-related changes in cerebral catecholamine and indoleamine metabolism. Lack of effect of adrenalectomy and corticosterone J. Neurochem. 51:1988;406-412.
23. Flugy A., Gagliano M., Cannizzaro C., Novara V., Cannizzaro G. Antidepressant and anxiolytic effects of alprazolam versus the conventional antidepressant desipramine and the anxiolytic diazepam in the forced swim test in rats. Eur. J. Pharmacol. 214:1992;233-238.
24. Fuller R.W., Snoddy H.D., Robertson D.W. Mechanisms of effects of d-fenfluramine on brain serotonin metabolism in rats. Uptake inhibition versus release Pharmacol. Biochem. Behav. 30:1988;715-721.
25. Ge J., Barnes N.M., Costall B., Naylor R.J. Effect of aversive stimulation on 5-hydroxytryptamine and dopamine metabolism in the rat brain. Pharmacol. Biochem. Behav. 58:1997;775-783.
26. Grealy M., O' Donnell J.M. Secretion of growth hormone elicited by intravenous desipramine in the conscious, unrestrained rat. Br. J. Pharmacol. 102:1991;369-372.
27. Harkin A., Kelly J.P., McNamara M., Connor T.J., Dredge K., Redmond A., Leonard B.E. Activity and onset of reboxetine and effect of combination with sertraline in an animal model of depression. Eur. J. Pharmacol. 364:1999;123-132.
28. Holsboer F., Barden N. Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocr. Rev. 17:1996;187-205.
29. Inoue T., Tsuchiya K., Koyama T. Regional changes in dopamine and serotonin activation with various intensity of physical and psychological stress in the rat brain. Pharmacol. Biochem. Behav. 49:1994;911-920.
30. Inoue T., Koyama T., Yamashita I. Effect of conditioned fear stress on serotonin metabolism in rat brain. Pharmacol. Biochem. Behav. 44:1993;371-374.
31. Jordan S., Kramer G.L., Zukas P.K., Petty F. Previous swim stress increases in vivo biogenic amine response to swim stress. Neurochem. Res. 19:1994;1521-1525.
32. Kawahara H., Yoshida M., Yokoo H., Nishi M., Tanaka M. Psychological stress increases serotonin release in the rat amygdala and prefrontal cortex assessed by in vivo microdialysis. Neurosci. Lett. 162:1993;81-84.
33. Kelliher P., Harkin A.J., Connor T.J., Sanchez C., Kelly J.P., Leonard B.E. Circadian alterations in the rat forced swim test. Behav. Pharmacol. 9(Suppl. 1):1998;S49.
34. Kelliher P., Connor T.J., Kelly J.P., Leonard B.E. Novel correlates of re-uptake inhibitor activity in the rat forced swim test. J. Psychopharmacol. Suppl. 12:1998;A12.
35. Kelly J.P., Leonard B.E. The effect of tianeptine and sertraline in three animal models of depression. Neuropharmacology. 33:1994;1011-1016.
36. Kirby L.G., Lucki I. Interaction between the forced swimming test and fluoxetine treatment on extracellular 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in the rat. J. Pharmacol. Exp. Ther. 282:1997;967-976.
37. Kitayama I., Janson A.M., Cintra A., Fuxe K., Agnati L.F., Ogren S.O., Harfstrand A., Eneroth P., Gustafsson J.A. Effects of chronic imipramine treatment on glucocorticoid receptor immunoreactivity in various regions of the rat brain. Evidence for selective increases of glucocorticoid receptor immunoreactivity in the locus coeruleus and in 5-hydroxytryptamine nerve cell groups of the rostral ventromedial medulla. J. Neural. Trans. 73:1988;191-203.
38. Leonard B.E. The mechanism of action of antidepressants. CNS Drugs. 4:1995;1-12.
39. Lloyd G.K., Cronin S., Fletcher A., Mitchell P.J. The profile of venlafaxine, a novel antidepressant agent, in behavioural antidepressant drug models. Clin. Neuropharmacol. 15(Suppl. 1):1992;428B.
40. McGarvey, C. M.: The effects of pharmacological modulation of the serotonergic system on some neuroendocrine, neurochemical and behavioural parameters in the rat. Ph.D. Thesis, National University of Ireland; 1995.
41. McGrath C., Norman T.R. The effect of venlafaxine treatment on the behavioural and neurochemical changes in the olfactory bulbectomised rat. Psychopharmacology (Berlin). 136:1998;394-401.
42. Mitchell P.J., Fletcher A. Venlafaxine exhibits pre-clinical antidepressant activity in the resident-intruder social interaction paradigm. Neuropsychopharmacology. 32:1993;1001-1009.
43. Nutt D.J. Venlafaxine. The yin and yang of antidepressants? J. Psychopharmacol. 9:1995;205-210.
44. Petty F., Kramer G., Wilson L., Jordan S. In vivo serotonin release in learned helplessness. Psychiatr. Res. 52:1994;285-293.
45. Popov N., Pohle W., Rosler V., Matthies H. Regionale verteilung von gamma-aminobuttersaure, glutaminsaure, asparaginsaure, dopamin, noradrenalin und serotonin in rattenhirm. Acta Med. Biol. Germ. 18:1967;695-702.
46. Porsolt R.D., Anton G., Blavet N., Jalfre M. Behavioural despair in rats. A new model sensitive to antidepressant treatment Eur. J. Pharmacol. 47:1978;379-391.
47. Przegalinski E., Budziszewska B. The effect of long term treatment with antidepressant drugs on hippocampal mineralocorticoid and glucocorticoid receptors in rats. Neurosci. Lett. 161:1993;215-218.
48. Redmond A.M., McNamara M.G., Dredge K., Kelly J.P., Leonard B.E. Onset of action of venlafaxine, citalopram and desipramine in the OB rat model of depression. J. Psychopharmacol. 11(Suppl 3):1997;A40.
49. Redrobe J.P., Bourin M., Colombel M.C., Baker G.B. Dose-dependent noradrenergic and serotonergic properties of venlafaxine in animal models indicative of antidepressant activity. Psychopharmacology (Berlin). 138:1998;1-8.
50. Reneric J.-P., Lucki I. Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test. Psychopharmacology (Berlin). 136:1998;190-197.
51. Reul J.M.H.M., Stec I., Soder M., Holsboer F. Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system. Endocrinology. 133:1993;312-320.
52. Reul J.M.H.M., Labeur M.S., Grigoriadis D.E., DeSouza E.B., Holsboer F. Hypothalamic-pituitary-adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide. Neuroendocrinology. 60:1994;509-519.
53. Seckl J.R., Fink G. Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippocampus in vivo. Neuroendocrinology. 55:1992;621-626.
54. Seyfried C.A., Adam G., Greve T. An automated direct-injection HPLC method for the electrochemical/fluorometric quantitation of monoamines and related compounds optimized for the screening of large numbers of animals. Biomed. Chromatogr. 1:1986;78-88.
55. Song C., Leonard B.E. Changes in behavior, neurotransmitters and neutrophil function in olfactory bulbectomized rats. Effects of chronic desipramine treatment Hum. Psychopharmacol. 12:1997;99-103.
56. Willner P. Animal models of depression. An overview Pharmacol. Ther. 45:1990;425-455.